| VRTX | Vertex Pharmaceuticals Inc | 8.14% |
| AMGN | Amgen Inc | 7.88% |
| GILD | Gilead Sciences Inc | 6.89% |
| REGN | Regeneron Pharmaceuticals Inc | 4.49% |
| ALNY | Alnylam Pharmaceuticals Inc | 2.81% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.23% |
| MRNA | Moderna Inc | 1.94% |
| ILMN | Illumina Inc | 1.86% |
| ARGX | argenx SE ADR | 1.79% |
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Invesco Nasdaq Biotechnology ETF · Issued by Invesco
No recent news for IBBQ. The ingest cron pulls every 15 minutes during market hours.